| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
ZVRA
Zevra Therapeutics
|
Jun 09, 2026 | BUY |
Strong Buy
+85.5% avg upside
15 analysts
|
$25.00
93.77% Upside
|
-7.7% |
|
RZLT
Rezolute
|
Jun 03, 2026 | BUY |
Strong Buy
+122.3% avg upside
13 analysts
|
$11.00
119.13% Upside
|
· |
|
ABVX
Abivax SA Sponsored ADR
|
Jun 02, 2026 | BUY |
Strong Buy
+20.7% avg upside
15 analysts
|
$187.00
88.58% Upside
|
+38.1% |
|
GHRS
GH Research
|
May 15, 2026 | BUY |
Strong Buy
+64.5% avg upside
11 analysts
|
$39.00
75.28% Upside
|
+1.5% |
|
PGEN
Precigen
|
May 14, 2026 | BUY |
Buy
+404.8% avg upside
11 analysts
|
$11.00
128.17% Upside
|
+2.8% |
|
AVTX
Avalo Therapeutics
|
May 14, 2026 | BUY |
Strong Buy
+265.1% avg upside
19 analysts
|
$55.00
274.09% Upside
|
-14.0% |
|
PRTA
Prothena
|
May 08, 2026 | BUY |
Buy
+160.9% avg upside
14 analysts
|
$20.00
123.95% Upside
|
-20.9% |
|
NERV
Minerva Neurosciences
|
Apr 15, 2026 | BUY |
Buy
+68.3% avg upside
8 analysts
|
$14.00
213.30% Upside
|
-32.2% |
|
NSRX
Nasus Pharma Ltd.
|
Mar 26, 2026 | BUY |
Strong Buy
+551.5% avg upside
2 analysts
|
$18.00
486.39% Upside
|
· |
|
ARGX
Argenx Se
|
Feb 27, 2026 | BUY |
Strong Buy
-15.8% avg upside
46 analysts
|
$944.00
7.63% Upside
|
+15.1% |
|
IRWD
Ironwood Pharma
|
Feb 26, 2026 | BUY |
Hold
+235.8% avg upside
23 analysts
|
$10.00
182.49% Upside
|
-3.8% |
|
ACAD
ACADIA Pharmaceuticals
|
Feb 26, 2026 | BUY |
Strong Buy
+66.0% avg upside
42 analysts
|
$35.00
61.96% Upside
|
-12.3% |
|
CYTK
Cytokinetics
|
Feb 25, 2026 | BUY |
Strong Buy
+8.9% avg upside
36 analysts
|
$96.00
21.93% Upside
|
+25.6% |
|
ACHV
Achieve Life Sciences
|
Nov 25, 2025 | BUY |
Strong Buy
+208.7% avg upside
12 analysts
|
$19.00
291.76% Upside
|
+16.8% |
|
RAPP
Rapport Therapeutics, Inc.
|
Nov 07, 2025 | BUY |
Strong Buy
+46.2% avg upside
12 analysts
|
$80.00
114.27% Upside
|
+43.7% |
|
HALO
Halozyme
|
Nov 04, 2025 | BUY |
Strong Buy
-13.7% avg upside
20 analysts
|
$92.00
34.15% Upside
|
+0.8% |
|
AQST
Aquestive Therapeutics
|
Oct 09, 2025 | BUY |
Strong Buy
+91.1% avg upside
10 analysts
|
$12.00
154.73% Upside
|
-35.6% |
|
ESPR
Esperion
|
Sep 22, 2025 | BUY |
Buy
+701.2% avg upside
22 analysts
|
$4.00
26.93% Upside
|
+25.5% |
|
CRMD
Cormedix
|
Sep 09, 2025 | BUY |
Strong Buy
+73.5% avg upside
13 analysts
|
$22.00
153.84% Upside
|
-34.5% |
|
LONA
LeonaBio
|
May 12, 2025 | HOLD |
Buy
+13.9% avg upside
9 analysts
|
— | +276.7% |
|
VRDN
Viridian Therapeutics
|
May 07, 2025 | BUY |
Strong Buy
+103.6% avg upside
32 analysts
|
$38.00
128.40% Upside
|
+38.3% |
|
SYRS
Syros Pharmaceuticals
|
Dec 27, 2024 | HOLD |
Buy
+10812400.0% avg upside
9 analysts
|
— | -99.6% |
|
TRVN
Trevena
|
Dec 27, 2024 | HOLD |
Buy
+128278.4% avg upside
11 analysts
|
— | · |
|
FR:POXEL
Poxel SA
|
Nov 03, 2023 | HOLD |
Hold
1 analyst
|
— | · |
|
QNCX
Quince Therapeutics
|
Jun 09, 2023 | HOLD |
Hold
+2771.2% avg upside
13 analysts
|
— | -50.0% |
|
QNRX
Quoin Pharmaceuticals
|
Apr 06, 2023 | HOLD |
Strong Buy
+661.3% avg upside
7 analysts
|
— | -85.5% |
|
BXRXQ
Baudax Bio
|
Sep 03, 2021 | HOLD |
Strong Buy
+18749999900.0% avg upside
3 analysts
|
— | · |
|
OVID
Ovid Therapeutics
|
Aug 16, 2021 | HOLD |
Strong Buy
+108.4% avg upside
17 analysts
|
— | -41.2% |
|
GB:0QW0
arGEN X
|
Feb 01, 2021 | BUY |
Strong Buy
-23.2% avg upside
24 analysts
|
$362.52
53.19% Downside
|
· |
|
LEN
Lennar
|
Jan 09, 2020 | BUY |
Hold
+7.5% avg upside
31 analysts
|
$70.00
21.91% Downside
|
+28.5% |
|
LRMR
Larimar Therapeutics
|
Sep 05, 2019 | HOLD |
Strong Buy
+413.5% avg upside
21 analysts
|
— | +45.8% |
|
TARA
Protara Therapeutics
|
Mar 28, 2019 | HOLD |
Strong Buy
+1153.9% avg upside
21 analysts
|
— | +9.3% |
|
VNDA
Vanda
|
Feb 14, 2019 | BUY |
Strong Buy
+253.1% avg upside
13 analysts
|
$52.00
796.56% Upside
|
-36.9% |
|
MRVSY
Minerva SA
|
Oct 18, 2016 | BUY |
Strong Buy
+200.8% avg upside
2 analysts
|
$17.00
423.12% Upside
|
· |
|
EVR
Evercore Partners
|
Jul 28, 2016 | BUY |
Buy
-31.4% avg upside
17 analysts
|
$61.00
83.63% Downside
|
+55.1% |
|
MNKD
MannKind
|
May 10, 2016 | HOLD |
Buy
+78.6% avg upside
22 analysts
|
— | -66.3% |
|
VCEL
Vericel
|
Aug 16, 2013 | BUY |
Strong Buy
+14.1% avg upside
16 analysts
|
$2.00
94.92% Downside
|
-44.0% |
|
SLS
SELLAS Life Sciences Group
|
May 22, 2013 | HOLD |
Strong Buy
+768.3% avg upside
15 analysts
|
— | -16.3% |
|
DCTH
Delcath Systems
|
May 06, 2013 | HOLD |
Strong Buy
+90.3% avg upside
11 analysts
|
— | · |
|
TCRT
Alaunos Therapeutics
|
Mar 26, 2013 | HOLD |
Buy
+603.1% avg upside
13 analysts
|
— | +169.8% |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.